Suppr超能文献

[原发性高血压患者群体及血压正常受试者血小板α2肾上腺素能受体的调节]

[Regulation of platelet alpha2 adrenergic receptors in a population of patients with essential arterial hypertension and in normotensive subjects].

作者信息

Fabris B, Fischetti F, Bulli G, Giraldi T, Castellano M, Beschi M G, Carretta R

机构信息

Istituto di Patologia Medica, Università degli Studi, Trieste.

出版信息

G Ital Cardiol. 1991 Jul;21(7):717-23.

PMID:1662651
Abstract

The development of specific binding techniques for the study of adrenergic receptors on circulating human blood cells has allowed a better understanding of the physiological alterations of adrenergic receptors and changes of adrenergic receptors in pathological conditions such as hypertension. Alpha adrenoceptors play an important part in blood pressure regulation at several sites. There are contradictory and conflicting reports on whether alpha receptor mechanisms are altered in essential hypertension. To address further the role of alpha 2 adrenoceptors in human essential hypertension the number and the affinity of alpha 2 adrenergic receptors and plasma catecholamine levels were measured in 20 normotensive and 24 hypertensive subjects. The median number of receptors (Bmax) was 159.10 +/- 14.38 fmol/mg protein for controls versus 179.09 +/- 13.26 fmol/mg protein for hypertensives. The median dissociation constant (KD) of the receptors for 3H-Yohimbine was 1.43 +/- 0.17 nmol/l for controls and 1.85 +/- 0.19 nmol/l for hypertensives patients. There were no differences in catecholamine plasma levels between the two groups. In controls platelet alpha 2 receptor number correlated with age (p less than 0.003) but not with blood pressure values. Our results show that measurement of platelet alpha 2 receptor levels and affinity is unable to differentiate a group of hypertensives from normotensives. Nevertheless, we cannot exclude a possible role of peripheral alpha 2 adrenergic receptors in the pathogenesis of high blood pressure.

摘要

用于研究循环人血细胞上肾上腺素能受体的特异性结合技术的发展,使人们能更好地理解肾上腺素能受体的生理改变以及在诸如高血压等病理状况下肾上腺素能受体的变化。α肾上腺素能受体在多个部位的血压调节中起重要作用。关于原发性高血压中α受体机制是否改变,存在相互矛盾和冲突的报道。为了进一步探讨α₂肾上腺素能受体在人类原发性高血压中的作用,对20名血压正常者和24名高血压患者测定了α₂肾上腺素能受体的数量和亲和力以及血浆儿茶酚胺水平。对照组受体的中位数数量(Bmax)为159.10±14.38 fmol/mg蛋白质,高血压患者为179.09±13.26 fmol/mg蛋白质。3H-育亨宾受体的中位数解离常数(KD),对照组为1.43±0.17 nmol/l,高血压患者为1.85±0.19 nmol/l。两组间血浆儿茶酚胺水平无差异。在对照组中,血小板α₂受体数量与年龄相关(p<0.003),但与血压值无关。我们的结果表明,测定血小板α₂受体水平和亲和力无法区分高血压组和血压正常组。然而,我们不能排除外周α₂肾上腺素能受体在高血压发病机制中可能起的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验